Search

Author/Creator Morrigan, B.

1. P675: TREATMENT OF HYPERTENSION IN PATIENTS RECEIVING BTK INHIBITORS: A MULTICENTER RETROSPECTIVE STUDY. (23rd June 2022)

Authors:
Shadman, M.; Voutsinas, J.; Fakhri, B.; Khajavian, S.; Spurgeon, S.; Stephens, D.; Skarnbik, A.; Mato, A.; Broome, C.; Gopal, A.; Smith, S.; Lynch, R.; Rainey, M.; Kim, S.; Barrett-Campbell, O.; Hemond, E.; Tsang, M.; Ermann, D.; Malakhov, N.; Rao, D.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
573
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. PHASE I/II STUDY OF UMBRALISIB (TGR‐1202) IN COMBINATION WITH UBLITUXIMAB (TG‐1101) AND PEMBROLIZUMAB IN PATIENTS WITH REL/REF CLL AND RICHTER'S TRANSFORMATION. (12th June 2019)

Authors:
Mato, A.R.; Svoboda, J.; Luning Prak, E.T.; Schuster, S.J.; Tsao, P.Y.; Dorsey, C.; Sarmasti, L.M.; Becker, P.S.; Brander, D.M.; Nasta, S.; Landsburg, D.J.; King, C.M.; Morrigan, B.; Elwell, J.; Kennard, K.; Roeker, L.; Zelenetz, A.D.; Purdom, M.; Paskalis, D.; Sportelli, P.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
119
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search